bictegravir (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

HIV Infection

Part of a once-daily single tablet regimen pending FDA approval for HIV infection that contains bictegravir (BIC) 50 mg, emtricitabine (FTC) 200 mg, and tenofovir alafenamide (TAF) 25 mg

See bictegravir/emtricitabine/tenofovir AF

Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.